Biotech / MedTech
Singapore’s ChemT Biotechnology raises $4M seed round to build AI intelligence layer for biomanufacturing
ChemT Biotechnology, an AI-driven biotechnology company based on Singapore, has closed a $4 million seed round led by Wavemaker Ventures and co-investment partner SEEDS, an arm of SG Growth Capital, with support from Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.
Melazyme raises $2M seed round from Thailand-based SeaX to scale precision fermentation platform
Melazyme, a precision fermentation startup focused on functional biomolecules, has raised $2 million in a seed funding round led by SeaX Ventures, with participation from Stellaris Venture Partners and Plug and Play Ventures.
Wavemaker Impact leads $700K pre-seed investment in Singapore’s Virdalis
Virdalis, a Singapore-based biotechnology company developing protein from Wolffia globosa—commonly known as duckweed—has secured US$700,000 in pre-seed funding led by Wavemaker Impact.
Gobi Partners invests in Cortical Labs, expands biological computing hub
Asia-focused venture capital firm Gobi Partners has invested in Cortical Labs, a biotechnology company developing computing systems that combine living human neurons with silicon hardware.
Malaysia’s Bioeconomy Corp eyes $540M revenue in 2026
The Malaysian Bioeconomy Development Corporation (Bioeconomy Corporation) is eyeing MYR 2.2 billion ($540 million) of revenue in 2026.
Temasek-backed D3 Bio secures $108M in Series B financing to advance global clinical programs
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, has announced the completion of a $108 million Series B financing round.
Singapore’s Bioactivx raises $1.43M in seed round led by Cocoon Capital
Bioactivx (BAX), a Singapore-based biomaterials startup, has closed its $1.43 million seed funding round led by Cocoon Capital, with participation from global strategic investors.
Petronas, Enilive and Euglen team up to launch new biorefinery in Pengerang Johor of Malaysia
Pengerang Biorefinery Sdn. Bhd., a joint venture between Petronas, Enilive S.p.A and Euglena Co., Ltd, marked a key milestone with the groundbreaking ceremony for the development of the new biorefinery in Pengerang, Johor, Malaysia.
Singapore’s Anomaly Bio raises $2.6M in pre-seed funding led by Pebblebed Ventures
Singapore-based biotech startup Anomaly Bio has raised $2.6 million in pre-seed funding led by the United States-based Pebblebed Ventures.
Nanyang Biologics announces $1.5B business combination with RF Acquisition Corp II to pursue Nasdaq listing
Nanyang Biologics Pte. Ltd. (NYB), together with its subsidiaries, announced the signing of a business combination agreement with RF Acquisition Corp II, a publicly listed special purpose acquisition company, to pursue Nasdaq listing.
